FFRCT without nitroglycerin shows promise in assessing coronary artery disease in severe AS patients undergoing TAVR, offering a non-invasive alternative.
# FFRCT, # severe AS, # TAVR
By Satoru Sasaki
https://t.co/rYJg1PyrQI
#circ_j #CardioTwitter https://t.co/tJ3ZbD9ROF